AI-driven Genetic Therapies Deep Genomics utilizes artificial intelligence to develop life-saving genetic therapies, presenting an opportunity to market innovative medical solutions to healthcare institutions and research organizations.
Financially Strong With revenues between $10M - $50M and $180M in funding, Deep Genomics showcases financial stability, providing a potential sales opportunity for financial services or investment firms seeking collaborations.
Industry Competitors Analysis By comparing employee sizes and revenues of similar biotech companies like BenevolentAI and Atomwise, sales teams can identify market positioning gaps and leverage Deep Genomics' strengths for competitive advantage.
Cutting-edge Technology Stack The tech stack featuring TensorFlow, Microsoft Azure, and more indicates a reliance on advanced tools. This presents a sales opportunity for tech service providers to offer complementary solutions or updates for efficiency.
Toronto Biotech Hub Presence Located in MaRS Discovery District, Toronto, Deep Genomics operates within a thriving biotech ecosystem. Sales professionals can leverage this to forge partnerships with other local biotech entities and tap into the regional market.
$50M$100M
$10M
$10M$50M
$10M
$10M$50M
$10M
$10M$50MDeep Genomics uses 8 technology products and services including NetSuite, Adobe Fonts, TensorFlow, and more. Explore Deep Genomics's tech stack below.
| Deep Genomics Email Formats | Percentage |
| First@deepgenomics.com | 86% |
| First.Last@deepgenomics.com | 11% |
| Last@deepgenomics.com | 3% |
Biotechnology ResearchToronto, Canada51-200 Employees
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Company Overview
Funding & FinancialsDeep Genomics has raised a total of $180M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180M.
Deep Genomics's revenue is in the range of $10M$50M
Funding & FinancialsDeep Genomics has raised a total of $180M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180M.
Deep Genomics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com